In the present study, we used the genetically modified apolipoprotein E deficient (ApoE−/−) mouse, a widely used mouse model of atherosclerosis and natural hypercholesterolemia, to study the effect of dyslipidemia on endothelial VCAM-1 expression. This evidence concerns the gene APOE and metabolic syndrome.